NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED

Autres langues NeuroScientific Biopharmaceuticals Limited

Actions

NSB

AU0000012973

Marché Fermé - Australian S.E. Autres places de cotation 03:28:06 14/05/2024			Varia. 5j.	Varia. 1 janv.
0,045 ^AUD	0,00%		-6,25%	+2,27%

20/03	NeuroScientific Biopharmaceuticals obtient un rabais fiscal de 2 millions de dollars australiens pour l'année fiscale 2023 ; les actions augmentent de 6%.	MT
27/02	NeuroScientific Biopharmaceuticals Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	20/03
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
NeuroScientific Biopharmaceuticals Limited Announces Changes to Board of Directors	05/12
NeuroScientific Biopharmaceuticals CEO to Step Down	01/12
NeuroScientific Biopharmaceuticals Limited Announces Resignation of Stephen Carter as CEO Effective 31 December 2023	01/12
Linda Friedland Steps Down from the Board of NeuroScientific Biopharmaceuticals Limited, Effective 17 November 2023	16/11
Neuroscientific Biopharmaceuticals Limited Announces Board Changes	12/11
NeuroScientific Biopharmaceuticals Ltd Appoints Linda Friedland as Independent Non-Executive Director	18/10/23
Neuroscientific Biopharmaceuticals Limited Announces Chief Executive Officer Changes	31/08/23
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25/08/23
Neuroscientific Biopharmaceuticals Announce Positive Treatment Effect in Multiple sclerosis Animal Study	14/03/23
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23
Neuroscientific Biopharmaceuticals Files New Patent for Multiple Sclerosis Treatment; Shares Jump 7%	05/12/22
NeuroScientific Biopharmaceuticals Files A New Patent, Entitled "Neuroprotective Compositions and Methods"	04/12/22
NeuroScientific Biopharmaceuticals Names Interim CEO; Shares Climb 12%	23/11/22
NeuroScientific Biopharmaceuticals Limited Announces Appointment of Mr. Paul Rennie as Interim CEO	22/11/22
NeuroScientific Biopharmaceuticals Limited Announces Management Changes	15/11/22
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as Managing Director	09/09/22
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as CEO	09/09/22
Neuroscientific Biopharmaceuticals Ltd. Announces HREC Decision to Not Approve Phase I Clinical Trial	07/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues NeuroScientific Biopharmaceuticals Limited

Actions

NSB

AU0000012973

Autres langues

Filtres